This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. For the past decade, the Oklahoma COBRE """"""""Science in a Culture of Mentoring"""""""" has been a pivotal resource in transforming OMRF into an institution committed to the mentoring and development of junior investigators to productive scientific careers. Through its support of 10 junior investigators, 9 pilot projects, and an evolving set of 8 cores, this resource has provided the infrastructure to help launch 12 independent research careers and support the subsequent funding of numerous multi-investigator grants (""""""""program grants"""""""") through other NIH Institutes. From inception, one of the primary goals of the IDeA/COBRE program was that these awards would be vehicles such that institutions in IDeA states could mature to the point of competing successfully for """"""""non NCRR"""""""" program grants. Prior to 2000 when RR15577 was funded, OMRF had but one NIH supported program project type grant in its 50 year history. In the ensuing decade we have been awarded TEN, all of which are directly linked to the topic/investigators of this COBRE. This COBRE grant has allowed the development of young investigators clustered around a major disciple in biomedicine, and with only a few exceptions, has RETAINED them within our institution/state. Thus, this proposal requests funds to continue the support of pivotal infrastructure in mentoring, team development, cutting-edge scientific cores and access to crucial human tissue samples for investigator development. Our Administrative Core will serve as a centralized governing resource for the COBRE, provide mentoring services to COBRE investigators and serve as a liaison between the Internal Advisory Committee, External Advisory Committee, institutional administration and COBRE Investigators. The scientific strategic purpose of the continuation of this COBRE is to support research in immunology and inflammation that impacts human health and disease.
The Specific Aims of this COBRE are to 1) Identify and Support Oklahoma COBRE Investigator Projects through Mentoring and Cores, 2) Implement and Expand Multidisciplinary COBRE Enrichment Programs, 3) Expand Collaborations between COBRE Investigators within and outside Oklahoma, 4) Coordinate, Integrate and Fiscally Manage to Financial Independence Research Cores which Meet and Extend the Scientific Opportunities of our COBRE Investigators, 5) Assist with Grant Applications, Management and Compliance Issues, 6) Evaluate and Manage the Effectiveness of Pilot Projects, Research Cores, and Mentoring and 7) Implement and Expand Data Sharing Strategies.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Center Core Grants (P30)
Project #
5P30RR031152-02
Application #
8364936
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Project Start
2011-08-01
Project End
2012-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
2
Fiscal Year
2011
Total Cost
$172,722
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Waubant, Emmanuelle; Mowry, Ellen M; Krupp, Lauren et al. (2013) Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler 19:891-5
Koelsch, Kristi A; Webb, Ryan; Jeffries, Matlock et al. (2013) Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun 41:168-74
Smith, Kenneth; Muther, Jennifer J; Duke, Angie L et al. (2013) Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology 218:745-54
Cogman, Abigail R; Chakravarty, Eliza F (2013) The case for Zostavax vaccination in systemic lupus erythematosus. Vaccine 31:3640-3
Ramos, Paula S; Oates, James C; Kamen, Diane L et al. (2013) Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. J Rheumatol 40:842-9
Lessard, Christopher J; Adrianto, Indra; Ice, John A et al. (2012) Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet 90:648-60
Wang, S; Adrianto, I; Wiley, G B et al. (2012) A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun 13:380-7
Adrianto, Indra; Wang, Shaofeng; Wiley, Graham B et al. (2012) Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 64:3695-705
James, Judith A; Robertson, Julie M (2012) Lupus and Epstein-Barr. Curr Opin Rheumatol 24:383-8
Niewold, Timothy B; Kelly, Jennifer A; Kariuki, Silvia N et al. (2012) IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis 71:463-8

Showing the most recent 10 out of 46 publications